Healthcare Industry Insights: April 2020

Thursday 30 April 2020

Europe Breast Pumps Market Research Report by Forecast to 2025

The Europe Breast Pumps Market size is expected to reach USD 676.53 million by 2025, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 7.9% during the forecast period. Increasing women employment, government initiatives aimed at improving consumer awareness, and improving healthcare infrastructure in emerging economies are the key driving factors.

Europe breast pumps market in developed economies, such as Germany, France, and Poland is saturated owing to increasing demand and presence of key market players. Economic development and rising disposable income are anticipated to help driving future sustainability for the regional market. Manufacturers investing in these rapidly developing markets are expected to witness high growth, provided pricing and distribution activities are undertaken effectively.

The end users in the Europe breast pump market, i.e. the lactating mothers, are becoming increasingly aware about the benefits and importance of breastfeeding. Increase in women employment and neonatal mortality rate is driving the adoption of advanced medical technologies in everyday lives of the consumers in this region. For instance, as per Global Economy, women employment rate in Germany increased from 54.51% in 2014 to 55.03% in 2017. Women in developed countries such as Germany and Poland are using technologically advanced devices in their everyday lives to reduce the time spent on routine activities. Such factors are anticipated to drive the regional market.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/europe-breast-pumps-market

Further key findings from the report suggest:

In terms of revenue, closed system segment is projected to ascend at the fastest CAGR over the forecast period. Ease of usage and better safety than the open system breast pumps can be attributed to the segment growth
Electric breast pumps commanded the highest market share in 2017 and is expected to witness the fastest growth over the forecast period owing to the increase in inclination towards technologically advanced products
Hospital grade breast pumps are expected to witness the fastest growth owing to the rising awareness regarding the benefit of breastfeeding and high employment rate among women
Some of the key companies present in the Europe breast pumps market are Ameda; Energizer Holdings, Inc.; Medela AG; Koninklijke Philips N.V.; Büttner-Frank GmbH; and Pigeon Corporation.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

U.S. Medical Coding Market Analysis & Forecast Report 2025

The U.S. Medical Coding Market size is expected to reach USD 7.0 billion by 2025 expanding at a CAGR of 9.3%, according to a new report by Grand View Research, Inc. There is a high demand for coding services in countries, which have high healthcare coverage and/or mandatory health insurance, as they are used in settling health insurance claims. Every individual has a unique combination of human genome. Although most of the time this variation does not affect the normal dosage regimen, it has an impact in the long term. Availability of several data enrichment tools, such as Electronic Health Records (EHRs) and m-Health, has reduced the communication gap between healthcare professionals and patients. These tools generate tremendous amount of data, which can be used for personalized treatment after translating them into coded language.

It can also be used for increasing the efficiency of various procedures including insurance claims, healthcare analytics, and medical billing. Many developed economies, such as U.S., are extensively using social media for increasing awareness about advanced healthcare. Thus, the advent of social media analytics is also anticipated to help enhance the efficiency in healthcare analytics. U.S. spends almost double the average of the global healthcare spending, which is expected to propel the market further.Major companies incorporate various strategies to gain competitive edge over others. For instance, recently Verisk Insurance Solutions started a joint venture with Guidewire to launch its ISO ClaimSearch accelerator. This initiative has provided Guidewire’s customers instant access to essential analytics of ISO ClaimSearch.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/us-medical-coding-market

Further key findings from the study suggest:

Outsourced services are anticipated to witness the fastest CAGR over the forecast period due to their low costs and better quality than in-house services
By classification system, the ICD segment is expected to lead the market due first-line use of these systems in classification of medical coding data
Some of the major companies in the U.S. medical coding market are STARTEK Health; Oracle Corporation; Verisk Analytics; Aviacode, Inc.; Parexel International Corporation; Maxim Health Information Services; Precyse Solutions, LLC.; and Medical Record Associates LLC.

Cold Plasma Market - Industry Analysis, Top Players, Revenue and Market Share Report

The global Cold Plasma Market size is expected to reach USD 198.50 million by 2026 at a strong CAGR of 15.2%, according to a new report by Grand View Research, Inc. Increasing use of cold plasma in medical treatment and rising cases of Hospital-Acquired Infections (HAI) are the key driving factors for the global market. In healthcare industry, plasma technology has been in use for some time and it continues to help improve various treatments. One of the major properties of cold plasma is the ability to kill bacteria and prevent infection. Therefore, it acts as an effective healing solution. It also accelerates healing process and prevent patient from discomfort.

Cold plasma is used in the treatment of chronic wounds and burns. The bacterial cells, including Multidrug Resistant (MDR) bacteria, are instantly killed after being exposed to cold plasma. As per an article published by the Medical Xpress, Med Tech Europe, around 4.0 million people in Europe suffer from non-healing wounds every year. It also reported that a burn patient in Germany was treated using prototype plasma treatment. Moreover, as per a research published by The National Center for Biotechnology Information (NCBI), a patient suffering with two second-degree burns was treated with cold plasma, which healed the itching and pain and presented new tissue after the second treatment. Such cases are anticipated to promote the usage of cold plasma in various wound treatments.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/cold-plasma-market

Further key findings from the study suggest:

In terms of revenue, atmospheric pressure segment is projected to ascend at the fastest CAGR over the forecast period due to rising application scope in various medical procedures
Wound healing application segment is expected to witness a significant growth over the forecast period
Asia Pacific region is estimated to witness the highest growth due to increased adoption of technologically advanced procedures for treatment of various diseases
Rise in disposable income levels and growing target population base are also likely to contribute to the region’s development
Some of the key companies in the global cold plasma market are U.S. Medical Innovations, LLC, Bovie Medical Corporation, Neoplas Tools GmbH, Europlasma N.V., and P2i Limited

Ophthalmic Packaging Market – Industry Analysis Report till 2026

The global Ophthalmic Packaging Market is expected to reach USD 15.20 billion by the end of 2026, according to a new report by Grand View Research, Inc. It is projected to expand at a 9.9% CAGR over the forecast period. Increasing global burden of ocular conditions and growing number of ophthalmic clinics, hospitals, and ambulatory care centers are the factors driving the market growth. Additionally, frequent introduction of new drug delivery systems and high demand for advanced packaging solutions is expected to fuel the market during forecast period.

Increasing healthcare expenditure and rising disposable income are some of the prominent factors that are expected to drive a lot of patients towards advanced ophthalmic care.

Furthermore, growing number of advanced healthcare facilities such as eye hospitals and ophthalmic clinics across several regions and increasing awareness about preventive care, ocular disorders and self-medications are some of the factors expected to aid to the market growth.

Increasing geriatric population coupled with age related ocular disorders is expected to increase the demand for ophthalmic products. Furthermore, the improving reimbursement policies for ocular surgeries including cataract & eye implants and increasing awareness about ocular disorders and treatment options is expected to drive the market growth.

The government and non-government initiatives such as ocular screening program and national healthcare program is expected to increase the accessibility to ophthalmic healthcare. Furthermore, the initiatives such as “economical free trade zone” & reducing approval time for establishment of facilities will contribute to the establishment of new ophthalmic manufacturing facilities that is expected to increase the demand for the packaging materials over the forecast period.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/ophthalmic-packaging-market

Further key findings from the report suggest:

Multiple dose ophthalmic packages held the largest market share in 2018 and expected to grow at a significant rate over the forecast period. Increasing usage of multiple dose packaging in OTC preparations coupled with growing prevalence of common ocular disorders such as red eyes, dry eyes, and conjunctivitis are the major factors expected to drive the growth.
Based on material, plastics packaging material accounted for the largest share and is expected to grow at a significant rate over the forecast period. Low density polyethylene (LDP) is the most preferred used resins due its advantages such as flexibility, compatibility, affordability and safety.
Based on type the ophthalmic packaging market is segmented into prescription and over the counter (OTC) products. The prescription type segment held the largest share in 2018 and is expected to grow at significant rate over the forecast period.
North America held around 38.5% of the global ophthalmic packaging material market in 2018. Developed healthcare infrastructure, rising ageing population, prevalence of eye disorders, and presence of stringent regulatory bodies are the factors contributing to the significant share.
Asia Pacific is anticipated to grow at fastest CAGR over the forecast period, the presence of several small and large scale ophthalmic manufacturing plants and large unmet healthcare needs.

Wednesday 29 April 2020

North America Long-term Care Software Market Analysis & Forecast Report 2025

The North America Long-Term Care Software Market size is anticipated to reach USD 2.1 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 12.4% over the forecast period. Aging baby boomers, growing incidence of chronic diseases, and government initiatives to include long-term care software in healthcare facilities are anticipated to drive the growth. With increasing demand for formal care, new technologies are being adopted to provide better and personalized care to the elderly, which is likely to further fuel the market during the forecast period.

The North America long-term care software market is likely to witness a high growth due to increasing geriatric population, awareness, and reforming healthcare infrastructure to provide affordable healthcare to senior citizens. According to the Health Trends Alberta projection, increasing geriatric population is expected to add USD 3.8 million to the health care costs of Canada by 2030.

Various strategic initiatives by market players are expected to boost the LTC software market growth. In August 2018, Mediware Information Systems acquired BlueStrata EHR to expand its long-term care software technology solutions. The acquisition is expected to support Mediware to meet healthcare needs of the aging population.

Moreover, various mergers and acquisitions are anticipated to fuel market growth. For instance, in October 2016, Netsmart acquired HealthMEDX to broaden its U.S. long-term care solutions for home care providers, nursing facilities, retirement communities, and assisted and independent living facilities.

Companies also focus on regional expansions through business collaborations. In April 2016, Good Shepherd Rehabilitation Network opted for Cerner Millennium clinical and financial management solutions to implement integrated Electronic Health Record (HER) system in 40 outpatient facilities in Eastern Pennsylvania, resulting in regional expansion for Cerner Corporation.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/north-america-long-term-care-software-market

Further key findings from the report suggest:

EHR accounted for the largest market share in 2017 owing to to better medical care and accurate patient information provided by the software
Cloud-based solution is anticipated to be the fastest growing segment during the forecast period due to cost-effectiveness, less operational issue, low investment, and ease of implementation with advanced security
U.S. dominated the North America long-term care software market and is likely to witness significant growth over the next decade due to rising aging population demanding long-term care coupled with need to lower the healthcare costs
Some of the key market players are Allscripts Healthcare Solutions, Inc.; Epic Systems Corporation; Cerner; McKesson Corporation; Omnicare; Omnicell, Inc.; MatrixCare; Optimus EMR; Netsmart; and PointClickCare.

Fractional Flow Reserve Market – Industry Analysis Report till 2026

The global Fractional Flow Reserve Market size is expected to reach USD 1.20 billion by 2026, according to a new report by Grand View Research, Inc. expanding at a CAGR of 10.4% over the forecast period. widening base of cardiovascular diseases coupled with mounting cases of diabetes in developed as well as developing economies is escalating the growth of the market. Furthermore, launch of novel devices in fractional flow reserve (FFR) market such as guidewires and monitoring systems are also anticipated to aid market growth. For instance, in May 2019, Philips launched IntraSight interventional applications platform. This platform offers comprehensive unit of IVUS, FFR, IFR and co-registration modalities to speed up the routine procedures and simplify complex interventions.

In an independent study by SCAI, in 2019 it was observed that FFR possess the capability to decide the treatment plan for Acute Coronary Syndrome (ACS) which could be either PCI (Percutaneous Coronary Intervention) or CABG (Coronary Artery Bypass Grafting). This is anticipated to help the physicians and provide effective treatment plan to patients, thereby increasing adoption of the same in coming five years.

Moreover, consolidation activities, such as acquisition of St. Jude by Abbott in 2017 in order to increase its foothold in the cardiovascular devices market, is likely to keep the market highly competitive and thereby, augur well for the overall market.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/fractional-flow-reserve-ffr-market

Further key findings from the report suggest:

FFR monitoring systems accounted for significant share of over 40.0% in 2018 owing to the extensive usage in single and multiple vessel CAD.
FFR guidewires is expected grow at a profitable growth rate over the forecast period due to increase in fractional flow reserve procedures conducted globally.
North America held the significant share of FFR devices industry as of 2018, due to the increased investment in R&D by the medical device companies. For instance, a bill was approved by the U.S. congress in May 2018 via which an individual can try unproven medical aids comprising drugs, medications and devices in case of severe illness.
Asia Pacific regional FFR industry is anticipated to witness major growth due to rising healthcare spending and rise in diabetes cases in countries such as China and India.
Some of the key companies operating in the fractional flow reserve market are OPSENS Medical, Abbott Laboratories, Boston Scientific, and Bracco S.p.A. among others.
The industry participants are engaged in extensive research activities to develop novel FFR devices for diagnosis of cardiac disorders.

Cancer Immunotherapy Drug Discovery Outsourcing Market - Industry Analysis, Top Players, Revenue and Market Share Report

The global Cancer Immunotherapy Drug Discovery Outsourcing Market size is projected to reach USD 1.7Billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 13.5% during the forecast period. Increasing prevalence of cancer and rising mortality associated with cancer, along with growing development in the field of cancer immunotherapy, are anticipated to stimulate the growth of the market.

In order to maintain pace with increasing competition in the cancer therapeutics industry, pharmaceutical companies spend 2.5% more than other high tech industries in the in-house R&D. Hence, they are swiftly shifting towards outsourcing of drug discovery in order to achieve lower in-house R&D costs.

Additionally, favorable tax credit allows pharmaceutical companies to appropriately plan their global projects with a reputed CRO and therefore, receive benefits and reduce problems associated with taxation authorities or other bodies administering such incentive programs.

Several new molecules for cancer immunotherapy and new immunotherapeutic options, such as tumor infiltrating lymphocytes, check point inhibitors immunomodulators, and CAR-T cell therapy, have been introduced. Some are in the pipeline and are being tested for their ability to provide better cancer treatment

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-drug-discovery-outsourcing-market

Further Key Findings From the Report Suggest:

Monoclonal antibodies emerged as the largest segment in 2017 because of increasing regulatory approvals and higher efficacy
Target identification and validation accounted for the largest share in the global market owing to higher costs incurred and increased investments in new drug development
North America dominated the market with the largest share in 2017. Rising incidence of cancer and increasing demand for novel technologies are facilitating the dominance of the region during the forecast period
Some of the key players are Covance, Inc.; Explicyte; Aquila BioMedical; Horizon Discovery Group PLC; Crown Bioscience, Inc.; Promega Corporation; HD Biosciences Co., Ltd.; BPS Bioscience, Inc.; Genscript Biotech Corporation; DiscoverX Corporation; Celentyx Ltd.; ImmunXperts SA; Personalis, Inc.; STC Biologics; and Molecular Imaging, Inc. dominated the cancer immunotherapy drug discovery outsourcing market.

Flexible & Semi-rigid Ureteroscopy Market - Industry Analysis, Top Players, Revenue and Market Share Report

The global Flexible & Semi-Rigid Ureteroscopy Market size is expected to reach USD 1.12 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 5.1% over the forecast period. Increasing incidence of urolithiasis coupled with growing geriatric and obese population is likely to drive the market. Furthermore, introduction of technologically advanced products is also projected to drive the growth.

According to the U.S. Department of Commerce, in 2015, the world population was 7.3 billion, out of which around 8.5% or 617.1 million people were aged 65 years and more. The rapid increase in elderly population is likely to drive growth of the market for flexible and semi-rigid ureteroscopy over the forecast period.

Ureteroscopy is an ideal and safe choice for treating ureteral stones, tumors or strictures. Introduction of technologically advanced products in terms of size and design has allowed ureteroscopes to easily access ureter and kidney, eliminating the need for any surgical incision. Also, with semi-rigid and flexible ureteroscopes; almost all parts of urinary tract can be easily assessed, with high quality digital optics enabling accurate assessment of mucosal lesions and stones.

Introduction of technologically advanced products such as single-use ureteroscopes is driving the market. For instance, Boston Scientific launched LithoVue, a new single-use digital ureteroscope, in U.S. and Europe. It provides high-quality digital visualization and seamless navigation for constant clinical performance during each procedure. Flexible ureteroscopes was the largest product segment in 2017 and is likely to witness fastest growth over the forecast period. The wide usage of these products is attributed to their accuracy and cost effectiveness.

Browse Details of Report@
https://www.grandviewresearch.com/industry-analysis/flexible-semi-rigid-ureteroscopy-market

Further key findings from the report suggest:

The urolithiasis segment is expected to hold largest market share, mainly due to the high prevalence of kidney stone
Hospitals was the largest segment of the flexible and semi-rigid ureteroscopy in 2017 as majority of diagnostic tests are performed in hospitals, mainly due to easy access
Ambulatory surgical centers segment is expected to witness significant growth over the forecast period. As the payers and government analyze costs and shift towards value-based care, outpatient surgery is likely to witness a rise
North America was the largest revenue generating region in 2017, followed by Europe. North America is the most well-established region in terms of usage of ureteroscopes and makes up most of the existing market
Asia Pacific is likely to witness the fastest growth over the forecast period due to unmet clinical needs and requirement for better diagnosis. Growing government initiatives and clinical research activities for advanced diagnostics are expected to further propel the regional growth
The players operating in this space are Boston Scientific, Olympus, Karl Storz Medical AG, Stryker, Elmed Medical Systems, Maxer Endoscopy, Richard Wolf, and Vimex Endoscopy. Most companies adopt strategies such as geographic expansion, business collaborations, and introducing technologically advanced products to increase their market share.

Tuesday 28 April 2020

3D Printed Surgical Models Market Research Report by Forecast to 2026

The global 3D Printed Surgical Models Market size is expected to reach USD 1.1 billion by 2026, expanding at a CAGR of 10.3%, according to a new report by Grand View Research, Inc. Improving diagnosis as well as the context of the patient’s pathology is driving the market. Increasing use of advanced healthcare technologies for better understanding of patients and minimization of risk during the actual surgical procedure is boosting the demand for 3D printed surgical models.

The introduction of synthetic modeling of human anatomy has made a significant leap forward. The 3D printed surgical models allow preadoption of surgical instruments by improving the 3D perception of the planned operation. The technology also enables surgeons to envision, practice, and then perform the actual surgery for saving time and increasing precision. These models can also be used to perform mock surgeries, thereby improving the prediction of the outcomes.

Advanced medical models are anatomically accurate, highly functional, and biomechanically realistic and are liberated from the cost and inconvenience to the animal as well as cadaver labs. They are perfect for simulating clinical procedures such as suturing, cutting, reaming, drilling, and even device placement. Some of the most advanced three-dimensional structures can even mimic bleeding, coming as close as possible to reality, which would enhance the efficiency and accuracy of surgical procedures.

The 3D printed anatomical models can help in numerous aspects, including educating young surgeons about tactile and three-dimensional inspection of the tissues. They are also used to help patients prepare for surgery.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/3d-printed-surgical-models-market

Further key findings from the report suggest:

The orthopedic surgery segment accounted for highest revenue in 2018 as the 3D models can assist in pre-operative planning by defining the geometry of bone loss, tumor mass, and nearby vessels to determine the most appropriate osteotomy site along with most appropriate prosthesis
The neurosurgery segment is anticipated to witness the fastest CAGR of 11.3% over the forecast period. This is due to increase in the use of 3D models to describe complex anatomical structures to patients
North America held the largest share accounting for 35.3% of the global market share in 2018. This is attributed to the U.S. offering the most sophisticated healthcare infrastructure comprising multispecialty hospitals and clinics, thereby increasing the demand
Some of the players operating in the market are Stratasys, Ltd.; 3D Systems, Inc.; Lazarus 3D, LLC; Osteo3d; Axial3D; Onkos Surgical; Formlabs, Materialise NV; 3D LifePrints UK Ltd.; and WhiteClouds.

Smart Insulin Pens And Pumps Market Analysis & Forecast Report 2026

The global Smart Insulin Pens And Pumps Market size is expected to reach USD 6.3 billion by 2026, registering around 10.0% CAGR over the forecast period according to a new report by Grand View Research, Inc. Major market drivers include continuous technological advancements in the field of diabetes care along with growing adoption of advanced diabetes management methods. The rising geriatric population coupled with the increasing incidence of diabetes as lifestyle associated disease are the factors expected to drive the product demand. Self-injection devices with integrated connectivity have become an important element of the digital ecosystem.

Smart insulin pens and pumps have created new standards for diabetes care. With the advent of Artificial Intelligence (AI), the entire paradigm of diabetes management has been transformed from simple Bluetooth enabled insulin delivery devices to an artificial pancreas. Furthermore, increasing investment and rising number of new product launches are expected to widen growth opportunities. For Instance, in July 2017, Cellnovo a French medtech company announced to raise USD 19.27 million to improve its product and to continue the R&D in artificial pancreas system. Many key players are focusing on technological collaborations, which is expected to have a long-term positive impact on the market. For instance, in September 2019, Medtronic collaborated with Novo Nordisk to integrate Novo future smart insulin pen dosage data with Medtronic CGM devices.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/smart-insulin-pens-pumps-market

Further key findings from the report suggest:

North America dominated the market in 2018 owing to favorable reimbursement policies, presence of key players, and high adoption rates for advanced technologies
By insulin pump types, Medtronic’s MiniMed accounted for the largest market share in 2018 and is expected maintain its dominance over the forecast period
Companion medical Inpen is expected to register the fastest CAGR over the forecast period, owing to high adoption rate and advanced features
By end use, hospital segment held the largest share of the smart insulin pens and pumps market in 2018. Homecare segment, on the other hand, is expected to register the fastest CAGR during the forecast period
The leading players present in the market are Companion Medical Inc.; Novo Nordisk; Emperra Gmbh E-Health technologies; Jiangasu Delfu medical device Co Ltd; Insulet Corporation;Cellenovo; Medronic Inc.; F Hoffmann-La Roche; Ypsomed; Tandem Diabetes Care; Sooil Development; Valeritas Inc.; and others. Major players are focusing on technological collaboration and product launches